XML 91 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Performance Shares, RSUs, Restricted Stock and Share Unit Awards) (Details)
12 Months Ended
Jul. 31, 2021
USD ($)
$ / shares
shares
Jul. 31, 2020
USD ($)
$ / shares
shares
Jul. 31, 2019
USD ($)
$ / shares
shares
Jul. 31, 2018
$ / shares
shares
Jul. 31, 2016
Dividend Equivalents [Abstract]          
Accrued during the period | $ $ 380,000 $ 294,000 $ 327,000    
Carrying value at period end | $ 492,392,000 380,348,000      
Income tax benefit from settlement of stock-based awards | $ $ 142,000 $ (224,000) $ 479,000    
Performance Shares, RSUs, Restricted Stock and Share Units          
Awards (In Shares)          
Outstanding, Beginning Balance (in shares) 999,574 954,676 818,438    
Granted (in shares) 644,272 560,361 442,363    
Settled (in shares) (455,564) (431,581) (275,619)    
Canceled/Forfeited (in shares) (119,912) (83,882) (30,506)    
Outstanding, Ending Balance (in shares) 1,068,370 999,574 954,676 818,438  
Vested, Ending Balance (in shares) 373,522        
Vested and Expected to Vest, Ending Balance (in shares) 1,023,923        
Weighted Average Grant Date Fair Value          
Outstanding, Beginning Balance (in dollars per share) | $ / shares $ 21.15 $ 22.40 $ 19.78    
Granted (in dollars per share) | $ / shares 19.06 19.93 29.76    
Settled (in dollars per share) | $ / shares 17.09 22.02 26.05    
Canceled/Forfeited (in dollars per share) | $ / shares 18.42 22.84 25.52    
Outstanding, Ending Balance (in dollars per share) | $ / shares 21.93 $ 21.15 $ 22.40 $ 19.78  
Vested, Ending Balance (in dollars per share) | $ / shares 21.84        
Vested and Expected to Vest, Ending Balance (in dollars per share) | $ / shares $ 21.93        
Aggregate Intrinsic Value          
Outstanding, Ending Balance | $ $ 26,677,000        
Vested, Ending Balance | $ 9,327,000        
Vested and Expected to Vest, Ending Balance | $ 25,567,000        
Additional Disclosures          
Total intrinsic value relating to fully vested stock-based awards converted during the period | $ $ 9,878,000 $ 9,635,000 $ 8,772,000    
Performance shares | Employees | Granted since fiscal 2014          
Additional Disclosures          
Performance period (in years) 3 years        
RSUs and restricted stock | Employees          
Additional Disclosures          
Vesting period (in years) 5 years        
Common stock, conversion ratio (in shares) 1        
RSUs and restricted stock | Non-Employee Director          
Additional Disclosures          
Vesting period (in years) 5 years     3 years  
Common stock, conversion ratio (in shares)       1  
Share units          
Awards (In Shares)          
Granted (in shares) 253,257        
Additional Disclosures          
Common stock, conversion ratio (in shares)         1
Conversion period of vested share units 1 year        
Granted units converted into common stock (in shares) 266,354        
Number of shares issued as result of conversion 98,502        
Number of units settled to date (in shares) 949,357        
Dividend equivalents          
Dividend Equivalents [Abstract]          
Accrued during the period | $ $ 380,000 294,000 327,000    
Paid during the period | $ 279,000 288,000 $ 263,000    
Carrying value at period end | $ $ 884,000 $ 783,000